Tower Research Capital LLC (Trc) Oramed Pharmaceuticals Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,389 shares of ORMP stock, worth $29,857. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,389

Previous 2,662 365.4%

Holding current value

$29,857

Previous $7,000 342.86%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.07 - $2.83 $20,134 - $27,527	9,727 Added 365.4%	12,389 $31,000
Q1 2024 May 15, 2024	BUY	$2.18 - $3.58 $4,525 - $7,432	2,076 Added 354.27%	2,662 $7,000
Q4 2023 Feb 13, 2024	SELL	$1.71 - $2.57 $2,831 - $4,255	-1,656 Reduced 73.86%	586 $1,000
Q3 2023 Nov 14, 2023	SELL	$2.51 - $3.55 $17,826 - $25,212	-7,102 Reduced 76.01%	2,242 $5,000
Q2 2023 Aug 14, 2023	BUY	$2.12 - $4.47 $19,737 - $41,615	9,310 Added 27382.35%	9,344 $33,000
Q1 2023 May 09, 2023	SELL	$1.93 - $13.1 $2,454 - $16,663	-1,272 Reduced 97.4%	34 $0
Q4 2022 Feb 10, 2023	BUY	$5.88 - $12.03 $6,503 - $13,305	1,106 Added 553.0%	1,306 $16,000
Q3 2022 Nov 10, 2022	SELL	$4.6 - $9.91 $7,576 - $16,321	-1,647 Reduced 89.17%	200 $1,000
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $75,672 - $183,078	-20,342 Reduced 91.68%	1,847 $9,000
Q1 2022 May 12, 2022	BUY	$8.19 - $13.89 $153,603 - $260,506	18,755 Added 546.16%	22,189 $192,000
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $35,539 - $81,455	2,738 Added 393.39%	3,434 $49,000
Q3 2021 Nov 15, 2021	SELL	$12.13 - $23.82 $29,075 - $57,096	-2,397 Reduced 77.5%	696 $15,000
Q2 2021 Aug 16, 2021	SELL	$8.34 - $14.59 $16,012 - $28,012	-1,920 Reduced 38.3%	3,093 $41,000
Q1 2021 May 17, 2021	BUY	$4.22 - $11.33 $20,196 - $54,225	4,786 Added 2108.37%	5,013 $51,000
Q4 2020 Feb 16, 2021	BUY	$2.48 - $4.64 $562 - $1,053	227 New	227 $1,000
Q3 2020 Nov 16, 2020	SELL	$2.58 - $4.16 $10,588 - $17,072	-4,104 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.87 - $4.12 $1,090 - $1,565	380 Added 10.2%	4,104 $14,000
Q1 2020 May 15, 2020	BUY	$2.6 - $5.5 $7,449 - $15,757	2,865 Added 333.53%	3,724 $11,000
Q4 2019 Feb 07, 2020	SELL	$2.43 - $5.74 $42,845 - $101,207	-17,632 Reduced 95.35%	859 $4,000
Q3 2019 Nov 05, 2019	BUY	$2.88 - $3.96 $48,951 - $67,308	16,997 Added 1137.68%	18,491 $59,000
Q2 2019 Aug 13, 2019	SELL	$2.88 - $4.36 $34 - $52	-12 Reduced 0.8%	1,494 $5,000
Q1 2019 May 14, 2019	BUY	$2.95 - $3.64 $4,442 - $5,481	1,506 New	1,506 $5,000
Q4 2018 Feb 14, 2019	SELL	$3.0 - $4.94 $2,583 - $4,253	-861 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$4.64 - $7.11 $3,995 - $6,121	861 New	861 $4,000
Q2 2018 Aug 15, 2018	SELL	$6.29 - $8.22 $1,767 - $2,309	-281 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.51 - $9.14 $976 - $1,371	150 Added 114.5%	281 $2,000
Q4 2017 Feb 09, 2018	SELL	$7.95 - $11.15 $2,082 - $2,921	-262 Reduced 66.67%	131 $1,000
Q3 2017 Nov 14, 2017	BUY	$7.74 - $10.78 $3,041 - $4,236	393	393 $4,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

6.37M

Call Options Held

Put Options Held

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $93.6M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Oramed Pharmaceuticals Inc. Transaction History